EROSIVE STRUCTURAL CHANGES AND THE IMPACT OF ANTI-TNFA THERAPY IN THE SPINE OF PATIENTS WITH ANKYLOSING SPONDYLITIS

被引：0

作者：

Baraliakos, X. ^{[1
]}

Listing, J. ^{[2
]}

Rudwaleit, M. ^{[3
]}

Sieper, J. ^{[3
]}

Braun, J. ^{[1
]}

机构：

[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, D-4690 Herne, Germany

[2] German Rheumatism Res Ctr, Berlin, Germany

[3] Univ Med Berlin, Dept Rheumatol, Berlin, Germany

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2010年 / 28卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：606 / 607

页数：2

共 50 条

[41] Can structural changes be reduced in ankylosing Spondylitis (AS) [J].

Sieper, J. .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 :30-31

[42] DISCONTINUATION OF ANTI-TNF-ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS [J].

Vasiljeva, H. G. ;

Elonakov, A. V. ;

Gorenkov, R. V. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 :1024-1024

[43] THE INFLUENCE OF SMOKING ON RESPONSE TO ANTI TNF THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS [J].

Anghel, D. ;

Jurcut, C. ;

Anghel, A. ;

Negru, M. M. ;

Savulescu, A. E. ;

Panturu, L. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) :S67-S68

[44] Anti-TNF-α therapy in ankylosing spondylitis [J].

Wendling, D ;

Toussirot, E .

EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (07) :1497-1507

[45] Physical therapy in anti-TNF treated patients with ankylosing spondylitis [J].

Dubey, S. G. ;

Leeder, J. ;

Gaffney, K. .

RHEUMATOLOGY, 2008, 47 (07) :1100-1101

[46] SERUM INDIAN HEDGEHOG (IHH) LEVELS ARE INCREASED IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS). ANTI-TNFA TREATMENT DECREASES SERUM IHH LEVELS IN PATIENTS WITH AS AND AFFECTS THE EXPRESSION OF FUNCTIONAL TARGET GENES IN A CELL LINE MODEL [J].

Filippopoulou, A. ;

Daoussis, D. ;

Liossis, S. -N. ;

Bouris, P. ;

Klavdianou, K. ;

Karamanos, N. ;

Andonopoulos, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 :134-134

[47] A BASELINE GENE EXPRESSION-BASED PROGNOSTIC FOR ANTI-TNFa THERAPY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE [J].

Sakaram, Suraj ;

He, Yudong ;

Sweeney, Timothy .

INFLAMMATORY BOWEL DISEASES, 2021, 27 :S8-S8

[48] Two-Year Follow-up of Patients on Anti-TNFa Therapy Substituted to Certolizumab: SAVANT 2 [J].

Motlis, Andrew ;

Boktor, Moheb ;

Jordan, Paul ;

Alexander, Steven .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S317-S317

[49] Lympocytosis in patients with inflammatory bowel disease treated with anti-TNFa agents: is it significant? [J].

Soufleris, K. ;

Kafalis, N. ;

Charalampidis, M. ;

Fasoulas, K. ;

Pilpilidis, I. ;

Lazaraki, G. ;

Tzilves, D. ;

Markala, D. .

JOURNAL OF CROHNS & COLITIS, 2019, 13 :S322-S322

[50] DISCONTINUATION OF ANTI-TNFA IN PATIENTS WITH PSORIATIC ARTHRITIS: A SINGLE-CENTER EXPERIENCE [J].

Graceffa, D. ;

Lora, V. ;

Cristaudo, A. ;

Elia, F. ;

Morrone, A. ;

Bonifati, C. .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 :1318-1318

← 1 2 3 4 5 →